Publication

Back to Resources

07/09/2024 | Publication | Journal of Medical Economics

U.S. Payer Budget Impact of Using an AI-Augmented Cancer Risk Discrimination Digital Histopathology Platform to Identify High-Risk of Recurrence in Women with Early-Stage Invasive Breast Cancer

11/03/2023 | Publication | Clinical Breast Cancer

PreciseDx’s “Analytical Validation of a Digital Breast Cancer Test Predicting Recurrence in Early-Stage Breast Cancer” Featured in Clinical Breast Cancer

12/21/2022 | Publication | BMC

Development and Validation of an AI-Enabled Digital Breast Cancer Assay to Predict Early-Stage Breast Cancer Recurrence Within 6 Years

02/14/2022 | Publication

Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence

09/03/2021 | Publication

An AI-Digital Breast Cancer Risk Discrimination Platform Accurately Categorized Patients with Oncotype Dx Low Risk Recurrence Scores

05/15/2020 | Publication

The Journal of Urology

07/29/2019 | Publication

Artificial Intelligence in Neuropathology: Deep Learning-Based Assessment of Tauopathy

01/26/2018 | Publication

Development and Validation of a Novel Automated Gleason Grade and Molecular Profile that Define a Highly Predictive Prostate Cancer Progression Algorithm-Based Test

12/20/2016 | Publication

Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes

11/14/2014 | Publication

Overcoming Tumor Heterogeneity in the Molecular Diagnosis of Urological Cancers

1 2 NEXT >